FANCJ dependent pathways in replication stress
FANCJ dependent pathways in replication stress
批准号:
10219989
负责人:
Sharon B Cantor
金额:
$35.87万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-05 至 2023-08-31
关键词:
AcetylationAddressBRCA1 geneBRCA2 geneBindingBiochemical GeneticsBioinformaticsBiological AssayBreastBreast Cancer geneBypassCancer PatientCell ProliferationCell SurvivalCellsCisplatinClinicalComplexDNADNA DamageDNA Mismatch Repair Protein MLH1DNA RepairDNA Repair GeneDNA StructureDNA biosynthesisDNA lesionDNA replication forkDataDefectDiseaseElectron MicroscopyEngineeringEnsureEquilibriumFanconi Anemia-BRCA PathwayFanconi anemia proteinFanconi&aposs AnemiaFiberFunctional disorderGenesGenomeGenomic InstabilityGoalsHealthHereditary Breast CarcinomaHereditary Breast and Ovarian Cancer SyndromeKnowledgeLinkMLH1 geneMalignant NeoplasmsMalignant neoplasm of ovaryMismatch RepairModificationMolecularMutateMutationNull LymphocytesOncogenesOutcomePathway interactionsPatientsPhenotypePhosphorylationPlayProcessProteinsProteomicsRecoveryRegulationResearchResistanceRoleSMARCA3 geneSiteStressSupporting CellTestingTherapeuticTherapeutic InterventionTransitional CellTranslationsTumor Suppressionbiological adaptation to stresschemotherapygain of functiongene functiongenetic approachgenome integrityhelicaseimprovedinnovationinsightmutantrepairedreplication stresssingle moleculetherapeutic developmenttranscription factortumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary:
Great progress has been made in uncovering the proteins and pathways that function in the replication stress
response. In particular, the hereditary breast cancer genes, as well as genes mutated in Fanconi anemia (FA)
function in the replication stress response. It is now understood that loss of their function in the replication
stress response contributes to the sensitivity of associated tumors to chemotherapies, such as cisplatin.
However, the distinct functions for the BRCA-FA proteins are largely unknown. Here, we propose to analyze
DNA replication fork dynamics, replisome components, and identify patient mutations that have specific defects
in the replication stress response.
To define how a cell transitions from defective to dysregulated replication, we have engineered cells
expressing different mutant versions of the BRCA1-associated FANCJ also mutated in breast/ovarian cancer
and FA. Similar to BRCA1, we have uncovered that FANCJ functions to protect replication forks from collapse.
We also found that this FANCJ fork protection function requires its direct interaction with the mismatch repair
(MMR) protein, MLH1. This finding provides insight as to why cells lacking the FANCJ-MLH1 interaction fail to
recover from replication stress. We have also identified putative gain-of-function FANCJ mutants, such as the
BRCA1-interaction defective mutant, that circumvent replication stress, keep forks intact, and confer hyper-
resistance to replication stress inducing agents. In Aim 1, we will seek to define how FANCJ interactions direct
DNA replication fork dynamics. Given that FANCJ localizes to replication forks, displaces proteins, and
unwinds DNA, we hypothesize that disrupted vs dysregulated replication will reflect not only changes in DNA
structures, but also the proteins found at DNA replication forks. In Aim 2, we will seek to determine how
FANCJ contributes to the composition of the replisome in both unchallenged and at stressed replication forks.
Replication stress induces changes to FANCJ protein interactions and post-translation modifications. Some of
these changes occur at sites we found to be mutated in cancer patients. In Aim 3, we will seek to generate
FANCJ mutants resistant to replication stress induced changes to uncover mechanisms regulating FANCJ
function that are lost in cancer. Collectively, by defining how cells succumb to- or survive- toxic DNA damage
that normally interferes with replication, we will gain insight towards mechanisms transitioning cells from
defective to dysregulated replication in cancer.
!
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting replication stress avoidance in cancer
-
批准号:10362554
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2020
-
负责人:Sharon B Cantor
-
依托单位:
Defining BRCA replication dysfunction in therapy response
-
批准号:10190872
-
项目类别:
-
资助金额:$55.59万
-
财政年份:2020
-
负责人:Sharon B Cantor
-
依托单位:
Targeting replication stress avoidance in cancer
-
批准号:10608942
-
项目类别:
-
资助金额:$45.22万
-
财政年份:2020
-
负责人:Sharon B Cantor
-
依托单位:
Targeting replication stress avoidance in cancer
-
批准号:10116341
-
项目类别:
-
资助金额:$46.76万
-
财政年份:2020
-
负责人:Sharon B Cantor
-
依托单位:
Defining BRCA replication dysfunction in therapy response
-
批准号:10412057
-
项目类别:
-
资助金额:$54.48万
-
财政年份:2020
-
负责人:Sharon B Cantor
-
依托单位:
FANCJ dependent pathways in replication stress
-
批准号:10012292
-
项目类别:
-
资助金额:$3.69万
-
财政年份:2018
-
负责人:Sharon B Cantor
-
依托单位:
FANCJ dependent pathways in replication stress
-
批准号:10462515
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2018
-
负责人:Sharon B Cantor
-
依托单位:
FANCJ dependent pathways in replication stress
-
批准号:9605534
-
项目类别:
-
资助金额:$40.49万
-
财政年份:2018
-
负责人:Sharon B Cantor
-
依托单位:
Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian Cancer
-
批准号:9277423
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2014
-
负责人:Sharon B Cantor
-
依托单位:
Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian Cancer
-
批准号:8877458
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2014
-
负责人:Sharon B Cantor
-
依托单位:
Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian Cancer
-
批准号:8761053
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2014
-
负责人:Sharon B Cantor
-
依托单位:
BACH1/FANCJ Checkpoint, Recombination, and Chemoresistance
-
批准号:7388296
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2007
-
负责人:Sharon B Cantor
-
依托单位:
BACH1/FANCJ Checkpoint, Recombination, and Chemoresistance
-
批准号:8114972
-
项目类别:
-
资助金额:$32.39万
-
财政年份:2007
-
负责人:Sharon B Cantor
-
依托单位:
BACH1/FANCJ Checkpoint, Recombination, and Chemoresistance
-
批准号:7498956
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2007
-
负责人:Sharon B Cantor
-
依托单位:
BACH1/FANCJ Checkpoint, Recombination, and Chemoresistance
-
批准号:7653729
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2007
-
负责人:Sharon B Cantor
-
依托单位:
BACH1/FANCJ Checkpoint, Recombination, and Chemoresistance
-
批准号:7895046
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2007
-
负责人:Sharon B Cantor
-
依托单位:
FUNCTIONAL ANALYSIS OF BRCA1
-
批准号:6173659
-
项目类别:
-
资助金额:$3.92万
-
财政年份:2000
-
负责人:Sharon B Cantor
-
依托单位:
FUNCTIONAL ANALYSIS OF BRCA1
-
批准号:2896488
-
项目类别:
-
资助金额:$3.67万
-
财政年份:1999
-
负责人:Sharon B Cantor
-
依托单位:
FUNCTIONAL ANALYSIS OF BRCA1
-
批准号:2634006
-
项目类别:
-
资助金额:$2.62万
-
财政年份:1998
-
负责人:Sharon B Cantor
-
依托单位:
海外基金